Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,618.00    -46.00 (-0.99%)
Bid:
4,620.00
Ask:
4,624.00
Spread: 4.00 (0.087%)
Market Cap: £17.44b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Unaudited restated segmental information

10 Jun 2021 07:01

RNS Number : 4038B
Halma PLC
10 June 2021
 

HALMA plc

 

Unaudited restated segmental information

 

To aid the users' understanding of operating segment restatement,effective 1 April 2021

 

As stated in our half year results announcement dated 19 November 2020, from 1 April 2021 we have aligned our organisational structure and financial reporting with our purpose and focus on safety, environmental and health markets. From that date, we operate and report under three sectors, Safety, Environmental & Analysis, and Medical. As previously disclosed, the existing Process Safety sector will be combined with the Infrastructure Safety sector to form a single Safety sector, with the exception of our two Gas sensor companies (Crowcon and Sensit), which will move from Process Safety to Environmental & Analysis.

The tables in this document show financial information for these three new sectors, had they been in existence, for the full years ended 31 March 2020 and 2021.

The changes to sector reporting do not impact the historical consolidated results of Halma plc at the Group level. The numbers below are management restatements of segment financials provided for information and are unaudited.

We will report under these three sectors on a statutory basis for the first time for the 6 months to 30 September 2021.

 

Financial Years to 31 March 2021 and 31 March 2020

Total revenue

Year ended

31 March 2021

£m

Year ended

31 March 2020

£m

 

Change

%

 

Change OCCY* %

Safety

587.0

620.8

(5.5%)

(6.2%)

Environmental & Analysis

361.1

370.7

(2.6%)

(4.3%)

Medical

371.3

347.2

7.0%

(5.4%)

Inter-segmental revenue

(1.2)

(0.3)

Group

1,318.2

1,338.4

(1.5%)

(5.6%)

* On an organic constant currency basis

 

Segment profit before allocation of adjustments#

Year ended

31 March 2021

£m

Year ended

31 March 2020

£m

 

Change

%

 

Change OCCY* %

Safety

135.3

141.1

(4.0%)

(5.0%)

Environmental & Analysis

89.3

79.9

11.6%

11.3%

Medical

86.6

84.4

2.6%

(10.5%)

Group

311.2

305.4

1.9%

(2.3%)

 

# Adjustments include the amortisation and impairment of acquired intangible assets; acquisition items; significant restructuring costs; and profit or loss on disposal of operations. More information on alternative performance measures is available for each respective period in our results announcements and annual reports which are available on our website at www.halma.com.

* On an organic constant currency basis

 

Revenue and profit transferred from Process Safety to Environmental & Analysis

Year ended

31 March 2021

£m

Year ended

31 March 2020

£m

 

Change

%

Revenue

 

52.3

45.7

14.6%

Profit

 

11.9

10.5

10.8%

 

Return on sales

Year ended

31 March 2021

%

Year ended

31 March 2020

%

 

Change

%

Safety

 

23.1%

22.7%

0.4%

Environmental & Analysis

24.7%

21.6%

3.1%

Medical

 

23.3%

24.3%

(1.0%)

Group

21.1%

19.9%

1.2%

 

Revenue by sector and destination (all continuing operations) (by location of customer)

 

Year ended 31 March 2021

 

 

 

USA

£m

 

Mainland Europe

£m

 

 

UK

£m

 

AsiaPacific

£m

Africa Near and Middle East

£m

 

Other countries

£m

 

 

Total

£m

Safety

143.7

170.8

124.9

90.9

34.1

22.6

587.0

Environmental & Analysis

165.1

44.2

70.1

65.9

9.2

6.6

361.1

Medical

200.6

61.0

19.2

59.3

10.8

20.4

371.3

Inter Segmental

(0.6)

-

(0.6)

-

-

-

(1.2)

Group

508.8

276.0

213.6

216.1

54.1

49.6

1,318.2

 

For further information, please contact:

Halma plcAndrew Williams, Group Chief ExecutiveMarc Ronchetti, Chief Financial Officer

 

Charles King, Head of Investor Relations

 

+44 (0)1494 721 111

 

 

+44 (0)7776 685948

MHP CommunicationsAndrew Jaques/Giles Robinson

+44 (0)20 3128 8788

NOTE TO EDITORS

 

1.

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day.

 

Its purpose defines the three broad market areas where it operates:

 

· Safety: protecting life as populations grown and protecting worker safety.

 

· Environment: improving food and water quality, and monitoring air pollution.

 

· Health: meeting rising healthcare demand as growing populations age and lifestyles change.

 

It employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

 

In January 2021, Halma was named Britain's Most Admired Company 2020 by Management Today.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAEKNEFAFEAA
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.